JLE

European Journal of Dermatology

MENU

Hemorrhagic Kaposi sarcoma. Successful treatment with IFN‐α Volume 14, issue 1, January-February 2004

Figures

See all figures

Authors
Department of Skin and Venereal Diseases, Medical School, University of Ioannina, 45110 Ioannina, Greece Department of Histopathology, University Hospital of Ioannina, Ioannina, Greece Dermatopathologische Gemeinschaftspraxis, Friedrichshafen, Germany Department of Oncology, University Hospital of Ioannina, Ioannina, Greece

A 76‐year‐old woman with atypical hemorrhagic Kaposi sarcoma is presented. The patient was treated with recombinant interferon α‐2b (3,000,000 IU) subcutaneously, three times weekly for 6 months and twice weekly as maintenance dose for 14 months with excellent response and no recurrence after a 7 1/2 years of follow‐up.